SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-008170
Filing Date
2022-12-02
Accepted
2022-12-02 17:00:56
Documents
13
Period of Report
2022-12-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT xenetic_8k.htm   iXBRL 8-K 31100
  Complete submission text file 0001683168-22-008170.txt   244307

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE xbio-20221201.xsd EX-101.SCH 3665
3 XBRL DEFINITION FILE xbio-20221201_def.xml EX-101.DEF 26553
4 XBRL LABEL FILE xbio-20221201_lab.xml EX-101.LAB 36543
5 XBRL PRESENTATION FILE xbio-20221201_pre.xml EX-101.PRE 25177
7 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 5196
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 221442836
SIC: 2834 Pharmaceutical Preparations